Cypress Bioscience Inc. (NSDQ:CYPB) sold its diagnostics business to Exagen Diagnostics Inc.
The deal includes $4 million in up-front payments over two years, with additional milestone and royalty payments that could boost the value of the transaction to $8 million. All of Cypress’ diagnostics employees will be offered jobs at Exagen, according to Cypress.